Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kohn

Showing results (411-420 of 516) with videos related to

Pageof 52
Sort By:
Stem Cells (Dayton, Ohio)|October 30, 2018
Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA RepairAnastasia Lomova, Danielle N Clark, Beatriz Campo-Fernandez, et al.
Frontiers in Genome Editing|October 29, 2021
Global and Local Manipulation of DNA Repair Mechanisms to Alter Site-Specific Gene Editing Outcomes in Hematopoietic Stem CellsElizabeth K Benitez, Anastasia Lomova Kaufman, Lilibeth Cervantes, et al.
Molecular Therapy. Methods & Clinical Development|September 23, 2024
Lentiviral vectors for precise expression to treat X-linked lymphoproliferative diseasePaul G Ayoub, Julia Gensheimer, Lindsay Lathrop, et al.
The Journal of Allergy and Clinical Immunology|July 2, 2013
Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 yearsAntonia Kwan, Joseph A Church, Morton J Cowan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2003
American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cellsDonald B Kohn, Michel Sadelain, Cynthia Dunbar, et al.
Human Gene Therapy|December 16, 1998
Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablationC E Dunbar, D B Kohn, R Schiffmann, et al.
The Journal of Allergy and Clinical Immunology|December 3, 2013
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experienceWilliam T Shearer, Elizabeth Dunn, Luigi D Notarangelo, et al.
Stem Cell Research & Therapy|October 4, 2017
Differentiation of RPE cells from integration-free iPS cells and their cell biological characterizationRoni A Hazim, Saravanan Karumbayaram, Mei Jiang, et al.
Transplantation|August 17, 2022
Apheresis of Deceased Donors as a New Source of Mobilized Peripheral Blood Hematopoietic Stem Cells for Transplant ToleranceRebecca A Sosa, Thomas Mone, Bita V Naini, et al.
Cell Reports|May 31, 2018
Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM SyndromeCaroline Y Kuo, Joseph D Long, Beatriz Campo-Fernandez, et al.
Pageof 52

Showing results (411-420 of 516) with videos related to

Sort By:
Pageof 52
Stem Cells (Dayton, Ohio)|October 30, 2018
Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA RepairAnastasia Lomova, Danielle N Clark, Beatriz Campo-Fernandez, et al.
Frontiers in Genome Editing|October 29, 2021
Global and Local Manipulation of DNA Repair Mechanisms to Alter Site-Specific Gene Editing Outcomes in Hematopoietic Stem CellsElizabeth K Benitez, Anastasia Lomova Kaufman, Lilibeth Cervantes, et al.
Molecular Therapy. Methods & Clinical Development|September 23, 2024
Lentiviral vectors for precise expression to treat X-linked lymphoproliferative diseasePaul G Ayoub, Julia Gensheimer, Lindsay Lathrop, et al.
The Journal of Allergy and Clinical Immunology|July 2, 2013
Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 yearsAntonia Kwan, Joseph A Church, Morton J Cowan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2003
American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cellsDonald B Kohn, Michel Sadelain, Cynthia Dunbar, et al.
Human Gene Therapy|December 16, 1998
Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablationC E Dunbar, D B Kohn, R Schiffmann, et al.
The Journal of Allergy and Clinical Immunology|December 3, 2013
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experienceWilliam T Shearer, Elizabeth Dunn, Luigi D Notarangelo, et al.
Stem Cell Research & Therapy|October 4, 2017
Differentiation of RPE cells from integration-free iPS cells and their cell biological characterizationRoni A Hazim, Saravanan Karumbayaram, Mei Jiang, et al.
Transplantation|August 17, 2022
Apheresis of Deceased Donors as a New Source of Mobilized Peripheral Blood Hematopoietic Stem Cells for Transplant ToleranceRebecca A Sosa, Thomas Mone, Bita V Naini, et al.
Cell Reports|May 31, 2018
Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM SyndromeCaroline Y Kuo, Joseph D Long, Beatriz Campo-Fernandez, et al.
Pageof 52